Skip to main content

Table 1 Baseline and clinical characteristics among age groups*

From: Do site and type of metastasis in breast cancer show a changing pattern with increased age? A cross comparison of clinicopathological characteristics between age groups

Variables

Group 1 (n = 564)†

Group 2 (n = 4519)

Group 3 (n = 670)

p value

Tumor size—cm

 

2.70 ± 1.44

2.72 ± 1.37

2.73 ± 1.40

0.90

Breast side—no. (%)

Left

297 (52.7)

2339 (51.8)

357 (53.3)

0.727

Right

267 (47.3)

2180 (48.2)

313 (46.7)

Pathology subtype—no. (%)

Insitu

17 (3.1)a

129 (3)a

16 (2.5)a

< 0.001

Mucinous

2 (0.4)a

40 (0.9)a

14 (2.2)b

Medullary

25 (4.6)a

172 (4)a

17 (2.7)a

Papillary

2 (0.4)b

8 (0.2)b

6 (0.9)a

Invasive ductal

448 (82.4)b

3650 (83.8)b

512 (80.4)a

Invasive lobular

4 (0.7)a

151 (3.5)b

34 (5.3)c

Mixed pattern

25 (4.6)a

131 (3)b

13 (2)b

Other

19 (3.5)a

72 (1.7)b

25 (3.9)a

Insitu component—no. (%)

Yes

138 (31.1)

1058 (31.1)

161 (34.5)

0.326

No

306 (68.9)

2339 (68.9)

305 (65.5)

Tumor necrosis—no. (%)

Yes

169 (36.4)a

1536 (44.6)b

232 (48.9)b

< 0.001

No

295 (63.6)a

1908 (55.4)b

242 (51.1)b

Invasion—no. (%)

Lymphatic

49 (9.8)a

540 (13.7)b

87 (14.9)b

0.002

Vascular

5 (1)a

80 (2)b

16 (2.7)b

Preneural

36 (7.2)a

298 (7.6)a

54 (9.3)a

Lymphatic & preneural

7 (1.4)a

109 (2.8)a

25 (4.3)b

Preneural & vascular

2 (0.4)a

37 (0.9)a

8 (1.4)a

Lymphatic & vascular

108 (21.6)a

747 (19)a

87 (14.9)b

None

192 (38.5)a

1485 (37.8)a

212 (36.4)a

ER receptor—no. (%)

Positive

363 (68.6)a

3162 (74.4)b

475 (76.9)b

0.001

Negative

165(31.2)a

1082 (25.5)b

143 (23.1)b

PR receptor—no. (%)

Positive

335 (63.4)a

2906 (68.6)b

426 (69.7)b

0.102

Negative

193 (36.3)a

1324 (31.2)b

184 (30.1)b

HER2 receptor—no. (%)

Positive

151 (29.9%)a

942 (27.2%)a

84 (19.2%)b

< 0.001

Negative

354 (70.1%)a

2521 (72.8%)a

353 (80.8%)b

Stage—no. (%)

0

17 (3.5)a

129 (3.3)a

16 (3.1)a

0.016

1

101 (20.9)a

895 (22.9)a

122 (23.5)a

2

208 (43.1)a

1824 (46.7)a

272 (52.4)b

3

150 (31.1)a

1001 (25.6)b

102 (19.7)c

4

7 (1.4)a

59 (1.5)a

7 (1.3)a

Grade—no. (%)

1

70 (15.9)a

759 (21.9)b

139 (28)c

0.001

2

250 (56.7)a

1991 (57.4)a

275 (55.4)a

3

121 (27.4)a

713 (20.6)b

82 (16.5)c

Grade of nucleus—no. (%)

1

26 (12)a

215 (18.3)b

40 (29.9)c

< 0.001

2

97 (44.9)a

553 (47.2)a

57 (42.5)a

3

93 (43.1)a

404 (34.5)b

37 (27.6)b

  1. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2
  2. *Plus minus values are means and standard deviations unless stated otherwise. Superscript alphabets represent the results of the post-hoc test, and accordingly, different alphabets show significant difference between groups. “a” is statistically different from “b” and “c”, “b” is statistically different from “a” and “c”, and “c” is statistically different from “a” and “b”
  3. †Age group 1 represent those younger than 30 years old, age group 2 represents those between 30 and 60 years old, and age group 3 represents those older than 60 years old